|
Articles Note: This page is a summary of the Articles and Monthly Newsletters with details on topic coverage. These links are not activated. Following registration, members are able to access this information by clicking on the Members Section button in the menu list on the left. 1. Basic Set of Articles 2. Monthly Newsletter Topic Headings...December 2004 >> 3. Select Topics from Newsletters Prior to December 2004 ++++++++++++++ 1. Basic Set of Articles Which Approach is the One for Me? As the first in the set, this article outlines the importance of personal self-assessment in how one sees follicular lymphoma (fNHL) in his or her life, what innate feelings are present with regard to dealing with it and a confirmation of willingness to learn, act and manage the course of the disorder for long term survival. Overview of Follicular Lymphoma A general introduction and overview. Basic information, grade and staging, understanding the diagnosis and options available, the development of follicular lymphoma, probable causes and risk factors, survival statistics, host microenvironment and prognostic indicators for predicting survival time, scientifically-based targeted natural strategies, the importance of understanding transformation, summary, references. Follicular Lymphoma...Targeted Natural Strategies for Long-Term Survival A comprehensive, copyright document, the only one of its kind in the world, dedicated entirely to the long-term management of follicular lymphoma. The topic coverage is scientifically-based and fully-referenced. This information will enable the reader to get started right away with a plan of action. It is the result of years of research focused specifically on controlling fNHL as a manageable disorder, and without a doubt is a major factor leading to long-term success. Incidence, implications, how to predict and treat this important and probable event right from the beginning. A brief look at possible complications in classification of the grade. When to Treat...and With What One of the most controversial issues. Factors influencing when to treat (transformation, problematic nodes, bulky tumors, tempo, cosmetic concerns, history of natural regression, psychological factors). Treatment choices…with what? (What are the choices? Transformation, choices for grades 1, 2, 3a) Treatment Options and Sequencing A critically important article should it become necessary to treat. A complete list of standard treatments, with comments/suggestions for consideration by the patient in choosing a protocol in consultation with the clinician. Optimizing Chemotherapy Practical suggestions and means by which the effectiveness of chemotherapy can be improved...very important if treating a transformation. Follicular Lymphoma SmartSheet A summary of all the key points under the headings of: development of fNHL, diagnosis, survival factors, treatment related factors, lifestyle strategies, the basis for action.2. Monthly Newsletter Topic Headings May 2008 Introduction 1. Prominent Doctor "Extremely Low" in Vitamin D 2. Key Points re Vitamin D with a Personal Plan of Action 3. Epigenetics 4. Food Compounds That Kill Test-Tube Cancer Cells 5. Vitamin Supplements May Cause More Harm Than Good 6. Revlimid/Rituxin Treatment at M.D. Anderson for Relapsed fNHL 7. Root Canals 8. Statin Caution re Rituximab 9. Secondary Cancer after Zevalin 10. Nasty Springtime Chemicals 11. Latest Info on the Role of the Microenvironment re Survival with fNHL 12. Last Casts (Vacation Notification, Vancouver/Seattle Lymphoma Education Forums, Longer Days/Lower Melatonin, Bill C-51, Energy Fix Trumps Cancer Cure, "Gem of the Day") April 2008 1. Editorial...Applying the Best Research from the Last 5 Years 2. Vitamin D…Essential to Monitor 3. Bexxar/Zevalin After Chemo 4. Autologous SCT: In-Vivo Purging and Choice of Chemotherapy 5. Bendamustine (Treanda) Approval 6. PEP-C Update 7. What About the TNS Group While on Maintenance Rituximab? 8. PET After Transformation 9. Celiac? 10. Last Casts (Physical Activity and Breast Cancer; Discussion Board; Food Compounds that Kill Test-Tube Cancer Cells; "MyVax" fNHL Vaccine; Breath Test for Cancer; Why Gerson May Work…for Awhile; Integrated PET-MRI Scanner Developed; Chronic Fatigue Syndrome; The Bright Side of Lymphoma. March 2008 1. Editorial 2. Follicular Lymphoma ReVisited…Dr. Saul Rosenberg 3. Essence of the Targeted Natural Strategies 4. Harvesting Stem Cells? 5. Bendandi Vaccine…Full Details from a Member 6. High Dose Intravenous Vitamin C…Full Details From a Member 7. Infection…A Critical Factor in Managing fNHL 8. Bendamustine (Treanda) Update 9. PX-478 10. New Research…Sleep, Melatonin and Breast Cancer 11. Last Casts (Exercise and Longevity; Vitamin D Check; CT Scans…Protecting the Kidneys; Dr. Weil; Thirst; Searching the Topics; Notification When Away; Sometimes It’s Sad) February 2008 1. Introduction 2. Chemotherapy…Dramatic Responses With Optimization and R-CyP 3. Article Updates 4. Exercise, Sugar, Cancer and More…Connecting the Dots 5. Plastics Concerns…Bisphenol A 6. Maintenance Rituximab? [Two Key Charts] 7. Autologous SCT…Outcomes Based on Grade and Prognostic Indicators 10. Closing Gems January 2008 1. Commentary 2. Vaccine Update…Bad News/Good News 3. "Gentle" Chemo Prior to Transplant Leading to Cure? 4. Dr. Oliver Press Webcast on fNHL 5. Dr. Zelenetz Webcast on Transformation 6. Inflammation and Cancer…New Data (With Suggestions) 7. Beyond Rituximab 8. Tocotrienols 9. Doxorubicin Caution 10. Eat Fish…Lose Weight…Here’s How and Why December 2007 Introduction 1. In Support of the Michael Werner/LRF Initiative 2. Updated Stanford Survival Statistics…Can You Guess the Outcome? 3. Powerful New Tool to Forecast Survival and Transformation: Vascularization 4. Vitamin D Lamp 5. Controversy Corner: Pay-by-Results Drug Pricing? 6. Vaccine Update 7. Curcumin…Bioavailablity and a Caution With Rituximab 8. Flaxseed 9. Sugar and Cancer 10. Searching the Articles and Newsletters November 2007 Introduction (Discussion board, 5 years of steady growth, annual integrative clinic visit) 1. Three Phases in the Long-Term Management of Follicular Lymphoma 2. The Role of Science in Long-Term Management 3. Green Tea 4. (More On) The Importance of Sleep 5. Boosting the Immune System? Hmmm? 6. (More On) Scans 7. If Hope, Attitude and Emotional State Don’t Work…What Just Might? 8. Rituximab (Mabthera) Warning from the FDA (Fall, 2007) 9. Does fNHL Grade Influence Survival Outcome Following an SCT? 10. The Curability of Follicular Lymphoma? 11. An Example in Great Courage and Determination…Ray Lammie 12. CancerActive.com October 2007 Introduction 1. Inflammation and Cancer…Scientific American [Very Important] 2. Tumor Biology…and Why it Matters 3. Toward Better Pathology…and Why It’s So Important 4. Organochlorines and the Risk of NHL 5. Common Drugs to Enhance Chemotherapy…New Research 6. AT-101 7. Excellent New Health Info Site (Lymphoma/Lifestyle>>) 8. Hormone D (The Statistics Become More Incredible) 9. Avocados 10. Our Creative Members 11. Reflection on Lifestyle Strategies…Tracey Says it Well Breakfast Hints Next Month September 2007 Introduction 1. I’ve Relapsed! Now What? 2. The New Role of PET…Dead Nodes? 3. Research on the Cutting Edge…Lymphoma Breakthrough? 4. Physical Activity and Lymphoma 5. Recommended Source for Beta Glucans 6. Toby’s Lifestyles Summary 7. Mercury Dental Fillings 8. The Essence of Managing fNHL…Three Phases…Personal Lay Opinion Closing Thought(s) August 2007 Introduction 1. (More On) Optimizing Chemotherapy 2. Positive Autologous Stem Cell Transplant Results 3. Mozobil 4. R-Cy 5. (More On) Grade 3 6. R-788 7. Intensity Modulated Radiation Therapy (IMRT) 8. “Solid Gold” at the M.D. Anderson Cancer Center…and a Personal Theory
Closing Thought July 2007
1. Commentary (b) Celebrating 19 Years 2. Green Tea Conflict with Curcumin >> Updated Dietary Strategies 3. Dr. Cheson on Follicular Lymphoma 4. R-FC (Rituximab+Fludarabine+Cyclophosphamide) 5. Issues of the Month (a) Have I Transformed? (b) What Can Eventually Happen to Me? (c) Clarifying “Overall Survival” 6. Yes! There IS a Seasonal Variance in the Incidence of fNHL 7. Closing Thought June 2007
1. Commentary 2. The Lives We Lead: Who We Are and Why it Matters 3. What Do All the Natural Strategies Have in Common? The Telomere Hypothesis 4. Rituximab-Chlorambucil…New Research 5. Bexxar…Before, After and New Research 6. Clarifying the Acid/Alkaline Theory 7. A Simple Solution Toward a More Accurate PET Scan 8. Scientific Research Connecting Mental Stress to Cancer 9. A Clinical Trial With Dietary Supplements for Follicular Lymphoma
10. Closing Thought: Observations re Natural Regression May 2007 1. Commentary
(a) Appreciation 2. Potent New Breakfast 3. Superfoods Found to Cut the Risk of Cancer…and Who Says So 4. Follicular Lymphoma…An 80 Year Perspective 5. Treatment with Rituximab…Ongoing (Maintenance) vs. Treatment Upon Progression 6. More on Vitamin D and Hypercalcemia April 2007 1. Commentary (a) Recovery from Hip Surgery; Nodal Development (b) DCA…a Balanced Appraisal 2. Curcumin Induced Apoptosis at Low Concentration 3. Sun Exposure and Malignant Lymphoma 4. Hypercalcemia 5. Chlorambucil and an SCT 6. (More On) Malignant Stem Cells…the Inconvenient Truth 7. What We DON’T Know about Follicular Lymphoma 8. Natural Weed Killer Formula 9. Valsartan 10. Red Palm Oil for Vitamin E 11. Picking Up the Pieces March 2007 1. Commentary
(a) Hip Surgery 2. Targeted Natural Strategies …The Big Picture As an in-depth feature topic for this month, we take a detailed look at the many factors relevant to the targeted natural strategies including adoption, definition, applicability, selection, the role of immunity, plausible mechanisms of spontaneous regression, the body’s natural ROS cascade, the role of antioxidants, legitimate concerns, ongoing development. 3. Summary February 2007 1. Introduction 2. Cheap, Safe Drug Kills Most Cancers? 3. Zevalin and Bexxar On the Way Out? 4. Follicular Lymphoma and Inflammation 5. Green Tea and Milk Products Likely Don’t Mix 6. FDA OKs Vitamin C Trial for Cancer 7. Nappy Went Out with H. Pylori Summary Comment…100,000 miles January 2007 1. Commentary 2. A Vaccine That Works? The Bendandi Research 3. Knocking On the Door To Cure?...Dr. Dan Longo 4. The Healthiest State Has the Highest Rate of Lymphoma! 5. H.Pylori…New Research re fNHL Management 6. Microenvironment 7. Skin "Rash" 8. Intestinal Facts 9. Things to Watch For in the Year Ahead December 2006 1. Commentary 2. Malignant Stem Cells Demand a Whole New Direction 3. Harvesting Healthy Stem Cells 4. Where Are We At With Vaccines? 5. Unraveling the SR Puzzle…ROS? 6. Maintenance Rituximab by the Numbers, Through the Years 7. Discussion Board and Administrative Support 8. Thanks, Diane! November 2006 1. Commentary 2. Discussion Board on the Site 3. Specific Immune Markers Predict Survival Time 4. Key Management Issues 5. Risk Factors for Transformation 6. Follicular Lymphoma Under the Microscope 7. Dietary Suggestions Following Chemo 8. Suggestions for Sourcing Natural Products 9. Trans Fats…When It’s Fun to be Wrong 10. Jamie Reno October 2006 1. Commentary 2. Curcumin Tested on Follicular Lymphoma for the First Time 3. A Perspective on Natural Strategies (a) A Sure Source of Controversy (b) Who and Why? (c) The Key Factor? (d) Recognizing the Viewpoints (e) The Suggested Approach (f) A Team Effort (g) The Need for Better Science (h) The Pro-Active Human Spirit (i) Biochemistry Signals the Way Ahead 4. Controversy Corner…Research I’d Like to See 5. More Breakfast Comments/Ideas (a) Curcumin Absorption (b) Patrick’s Smoothy (c) Joan’s Brown Rice Recipe 6. Vitamin D…Myths, Facts, Statistics and the Need for Caution 7. A Review of Autologous SCT’s 8. An Easy Understanding of DNA, Genes and Chromosomes
September 2006 1. Commentary 2. Follow Up On the New Breakfast 3. Watch & Wait…My Friends Don’t Understand! 4. New Findings to Optimize Chemotherapy 5. Rituximab Clarity Needed in Canada 6. Sunshine and the Production of Natural Melatonin August 2006 1. Commentary 2. Last Node Goes to Science 3. Budwig Diet Reaffirmed…Now With the Science 4. New Scientific Data re Curcumin and fNHL 5. Histone Deacetylase (HDAC) Inhibitors 6. The New Recommended Breakfast 7. Vaccines: The Results, the Integrity, the Reality July 2006 1. Commentary 2. Professional Affiliations 3. More on Vitamin D, Ellagic Acid, Curcumin 4. Vegetables and Lymphoma 5. Toxoplasmosis 6. Music June 2006 1. Commentary 2. The Need for a Change in Management 3. The Seminar in Review 4. Understanding Follicular Lymphoma Leading to Successful Long-Term Management…a Brief Overview 5. Could There Be a Seasonal Variation in the Incidence Rate? 6. Reinforcing the "Hormone Twins" May 2006 1. Commentary…Springtime/Sunshine and the Seattle Seminar 2. Focus of These Newsletters 3. Follow-Up on the New Paradigm 4. The Genesis and Progression of Follicular Lymphoma 5. The Concept of Management 6. Bendamustine (Treanda) Re-Visited (Update) 7. Don’t We Just Wish! April 2006 1. Opening a New Chapter 2. Proven Spontaneous Regression 3. A Paradigm Shift in Understanding Follicular Lymphoma 4. A Paradigm Shift in Understanding Natural Therapies 5. Spontaneous Regression;Remission/Regression; Wax/Wane 6. Peggy's Story 7. Seattle Seminar March 2006 1. Commentary 2. Gene Expression Profiling, Upcoming Study 3. Predicting Survival...Blending the Old With the New 4. Strategy, Vision and the Planning Horizon 5. A Vaccine Trial for the "Heavy Hitters" 6. Melatonin 7. A Great Little Search Tool February 2006 1. Commentary 2. The fNHL Patient's Guide to Transformation 3. Maintenance Rituximab...Gaps in Comprehension? 4. Glutamine 5. Low-Fat Diets 6. An Aid to Searching the Site January 20061. Commentary 2. Vitamin D3 3. Noteworthy Research from Mayo 4. HuMax-CD20 (Update) 5. Personalized, Therapeutic Monoclonal Antibodies>>Beyond Rituxin? 6. Scan Comparisons 7. Macrophages in Connection with Survival 8. Navigating the System 9. Summary December 2005 1. Commentary (A turning point in research and treatment)2. Where Are We AT With Follicular Lymphoma? 3. Where Are We GOING With Follicular Lymphoma? 4. Two New Discoveries re Immunity 5. T-Cell Immunity…Fatty Acids 6. Alternative, Complementary and Integrative Therapies…What’s the Difference? 7. Reflections on Life; Strength for the Year Ahead 8. Summary: A Time to Give Thanks November 2005 1. Commentary 2. The Critical Importance of Balance 3. Chronic Hidden Infection 4. Accuracy/Honesty in Medical Reporting 5. Alkalinity: Fact or Fiction? 6. Flu Shots/Tamiflu 7. Zevalin Alert 8. Aspartame Link 9. Grass-Fed Beef 10. Preparing for Winter...Vitamin D3 and the New Cold Medications...That Work! October 2005 1. Commentary (Important Escapes, Phone Calls From Afar, Topic Overview) 2. Spontaneous Regression…A Personal Perspective 3. Enhancing Rituximab 4. Grade 3 5. A Well-Deserved 2005 Nobel Prize in Medicine…and Its Connection to Lymphoma 6. Pure Juices 7. Summary (Where Are We Really At? KALLing the Shots) September 20051. Commentary (Observations re First Treatment) 2. New Article: "When to Treat…and With What" 3. A Summary of First Treatment Options (a) Five Plausible Treatment Approaches (b) Prominent Specialists Discuss Treatment Options August 2005 1. Commentary (Topic Overview) 2. "Overview of Follicular Lymphoma"...Article Updated 3. Vaccine Results...Inconclusive, Disappointing? 4. FDG-PET Imaging 5. Cautionary Note re Rituximab Maintenance 6. Treatment Options..."Meet the Professors" 7. 2005 Educational Forum 8. Weird Breakfast Come Weird Supper July 2005 1. Commentary (Welcome) 2. New Article: "The Follicular Lymphoma SmartSheet" 3. Unique Environmental Perspective 4. Lance Armstrong 5. Off To the Mountains June 2005 1. T-Cell Immunotherapy 2. Controversy Corner...Maintenance Rituximab 3. Low Dose Naltrexone Re-Visited 4. Nutrient Absorption and Food Evaluation 5. Anti-Bacterial Soaps 6. Medical Dictionary 7. June May 2005 1. Commentary (First Time, New Features) 2. Seattle, Vancouver Conferences) 3. Vaccine Therapy Terminology 4. Controversy Corner...Survival 5. PET Scans 6. Sleep and Immunity 7. Membership Services on the Website April 2005 1. Commentary (Personal Update, Website, Seminar) 2. Making Sense of Recent Discoveries (Pathologist Gascoyne's Research Step by Step) 3. Familial Hematological Malignancy Project 4. Autologous Transplantation Follow Up March 2005 1. Commentary (Website Support) 2. Visits/Seminar 3. Recent Research...Where Are We At? 4. Pesticides 5. Dose Dense CHOP 6. Autologous Transplantation 7. Going the Distance...Physically, Mentally 8. Lymphoma Pin February 2005 1. Commentary (New Website, Bexxar News) 2. Microenvironment (Thoughts, Suggestions) 3. Bexxar in Balance 4. Your Doctor's Perspective 5. Nutritional Genomics (Phytochemicals...genetic signaling) 6. Sleep, Stress and Cancer 7. Curcumin/Green Tea Synergy 8. Excellent Book 9. Overseas Calls January 2005 1. Commentary 2. The Etiology of Follicular Lymphoma 3. The Futility of Watch and Wait 4. Allogeneic Bone Marrow Transplants 5. CPOP 6. Alcohol…Show Me the…’Urp Science 7. C, D, E, and F 8. Sherry Soups Up the Breakfast 9. Wear Yellow 10. Summary December 2004 1. Commentary 2. Follow-Up On the Recent Research 3. What We Need in Winter 4. More "Breakthrough" Research 5. HuMax-CD20 6. Bendamustine 7. Drugs in the News 8. Enhancing Rituximab (Mabthera) 9. "Chemopreventive Agents" 10. Wear Yellow 11. Summary 3. Select Topics from Newsletters Prior to December 2004
Chlorambucil...Rituximab...At Last Cookbook For Cancer Patients Dietary Factors in Connecticut Women Fludarabine vs. CHOP Results Fungal Mycotoxin in Cereal Grains Infectious Disease Associations Thoughts re Scanning Low Dose Naltrexone Maintenance Rituximab My Personal History Polio Vaccine and Lymphoma Prognostic Indicators Survival Study Exceptional Survival With Minimal Treatment Note: All educational material in the above articles and newsletters is written to be easily understood by the average reader. It is all based on scientific data. Key points are clearly referenced and the scientific references are detailed at the end of each article. Site designed by Zap BC |
